← Eichor
Condition: Brain Gliomas Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Brain Gliomas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05727605Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07193654Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT052712405G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Tr
Phase 2 · 12 location(s) · ECOG-ACRIN Cancer Research Group · NCT06319027WBSI Guided Personalized Delivery of TTFields
NA · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT05086497Tessa Jowell BRAIN MATRIX - Platform Study
Phase N/A · 14 location(s) · University of Birmingham · NCT04274283Metabolic Characterization of Space Occupying Lesions of the Brain
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04233788Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04099797SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05254197Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies
Phase N/A · 6 location(s) · Hospital Italiano de Buenos Aires · NCT076313385G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215Brain Connectivity Changes in Glioma Patients During Treatment
Phase N/A · 1 location(s) · Johannes Kepler University of Linz · NCT07612917A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refra
EARLY_Phase 1 · 1 location(s) · Children's National Research Institute · NCT07017816Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT06779487Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
NA · 1 location(s) · University of Miami · NCT05284643Evaluation of the CONVIVO System
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT05139277Development of MRF for Characterization of Brain Tumors After Radiotherapy
NA · 2 location(s) · Case Comprehensive Cancer Center · NCT06101069APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · 35 location(s) · Apollomics Inc. · NCT03175224Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NA · 1 location(s) · Medical University of Vienna · NCT06512311The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
NA · 5 location(s) · Jasper Gerritsen · NCT03861299DLL3 CAR-T Therapy Targeting Brain Tumors
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT07180927International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324NeuroPathways Intervention for Brain Tumor Patients
NA · 1 location(s) · Massachusetts General Hospital · NCT05976490
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.